MYM Announces Hiring of Greenhouse Expert Casey Houweling, for Weedon Project
VANCOUVER, British Columbia, May 29, 2018 /CNW/ -- MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC: MYMMF) ("MYM") is pleased to announce that it has engaged world renowned greenhouse expert Casey Houweling to oversee the set-up of greenhouse operations and best practices in growing and harvesting at the 1.5 million square foot, Weedon, Quebec project.
Mr. Houweling is founder and builder of one of the largest, most technically advanced and environmentally friendly greenhouse operations in the world – he is also President of Glass Investments Inc, a private consulting firm which specializes in greenhouse building and operating best practices.
The addition of Casey Houweling to the team is a giant step forward in establishing a world-class growing facility in Weedon, Quebec,
said Rob Gietl, CEO of MYM.
Mr. Houweling is a respected global leader in the greenhouse industry and will prove to be a valuable asset in the successful construction and operating practices of the 1.5 million square foot Weedon project. MYM understands that lower production costs achieved from large scale production will drive success in coming years. As competition ramps up, operations with higher costs will suffer as cannabis prices drop.
Over his career, Mr. Houweling has successfully designed intellectual property for the greenhouse industry which has lowered costs, improved yields, and reached the highest standard of product. Mr. Houweling will incorporate commercial techniques and systems gained from his greenhouse experience in Canada and the USA and apply them to the Weedon, Quebec project.
Simply put, his experience in building, operating and refining greenhouse technologies over his lifetime is without question unparalleled anywhere in the world.
Mr. Houweling will work with project experts and stakeholders to prepare a site layout, provide capital cost estimates, and design operating specifications suitable for a cannabis greenhouse. He will also assist in the financial feasibility studies and procurement of equipment from his global contacts.
About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a shareholder in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).
ON BEHALF OF THE BOARD
Rob Gietl, CEO
MYM Nutraceuticals Inc.
Keep up to date with MYM on our social media channels:
This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
SOURCE MYM Nutraceuticals Inc.